Search results
Results from the WOW.Com Content Network
One of its major applications is as a clinical assessment tool for clinicians to determine the severity of the addictions and the necessity for treatment through probing the patients' conditions in both health and social issues. 7 aspects including medical health, employment/ support status, drug and alcohol use, illegal activity and legal ...
Almost all scholarly articles on the subject of suspicionless drug testing of welfare recipients has concluded that this testing violates the Fourth Amendment to the United States Constitution. [13] For this reason many programs now involve initial screening with a psychological assessment tool, with those considered likely to have a drug ...
The Global Appraisal of Individual Needs (GAIN) is a family of evidence-based instruments used to assist clinicians with diagnosis, placement, and treatment planning. The GAIN is used with both adolescents and adults in all kinds of treatment programs, including outpatient, intensive outpatient, partial hospitalization, methadone, short-term residential, long-term residential, therapeutic ...
The CRAFFT [1] is a short clinical assessment tool designed to screen for substance-related risks and problems in adolescents. CRAFFT stands for the key words of the 6 items in the second section of the assessment - Car, Relax, Alone, Forget, Friends, Trouble. As of 2020, updated versions of the CRAFFT known as the "CRAFFT 2.1" and "CRAFFT 2.1 ...
2,5-Dimethoxyamphetamine (2,5-DMA), also known as DMA-4, is a drug of the phenethylamine and amphetamine families. [1] [2] It is one of the dimethoxyamphetamine (DMA) series of positional isomers. [1] [2] The drug is notable in being the parent compound of the DOx (4-substituted-2,5-dimethoxyamphetamine) series of drugs. [1] [2]
FDA Building 51 is one of the main buildings in its White Oak campus that houses the Center for Drug Evaluation and Research. The Center for Drug Evaluation and Research (CDER, pronounced "see'-der") is a division of the U.S. Food and Drug Administration (FDA) that monitors most drugs as defined in the Food, Drug, and Cosmetic Act.
Clinical Opiate Withdrawal Scale (COWS) is a method used by registered practitioners to measure the severity of a patient's opioid withdrawal symptoms. This method consists of a series of 11 topics each comprising 4–5 common symptoms experienced by a patient undergoing opioid withdrawal.
U.S. Army Public Health Center Toxicology Lab technician assessing samples. Toxicology testing, also known as safety assessment, or toxicity testing, is the process of determining the degree to which a substance of interest negatively impacts the normal biological functions of an organism, given a certain exposure duration, route of exposure, and substance concentration.